2011 GOLD Stages of COPD: Transitions, Predictor Factors and Comparison with 2017 GOLD Stages

References

• EisnerMD, BlancPD, YelinEH, et al. COPD as a systemic disease: impact on physical functional limitations. Am J Med. 2008;121(9):789–796. doi:10.1016/j.amjmed.2008.04.03018724969
   PubMed Web of Science ®Google Scholar
• CasanovaC, MarinJM, Martinez-GonzalezC, et al. New GOLD classification: longitudinal data on group assignment. Respir Res. 2014;15(1):3. doi:10.1186/1465-9921-15-324417879
   PubMed Web of Science ®Google Scholar
• AgustiA, EdwardsLD, CelliB, et al. Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort. Eur Respir J. 2013;42(3):636–646. doi:10.1183/09031936.0019521223766334
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease (GOLD) [homepage on the Internet]. Global strategy for the diagnosis, management and prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 Available from: http://www.goldcopd.org/. Accessed 611, 2019.
   Google Scholar
• LeLAK, JohannessenA, HardieJA, et al. Prevalence and prognostic ability of the GOLD 2017 classification compared to the GOLD 2011 classification in a Norwegian COPD cohort. Int J Chron Obstruct Pulmon Dis. 2019;14:1639–1655.31413559
   PubMed Web of Science ®Google Scholar
• SorianoJB, HahslerM, SorianoC, et al. Temporal transitions in COPD severity stages within the GOLD 2017 classification system. Respir Med. 2018;142:81–85. doi:10.1016/j.rmed.2018.07.01930170807
   PubMed Web of Science ®Google Scholar
• Medina-MirapeixF, Bernabeu-MoraR, Sánchez-MartínezMP, et al. Mobility limitations related to reduced pulmonary function among aging people with chronic obstructive pulmonary disease. PLoS One. 2018;13(5):e0196152. doi:10.1371/journal.pone.019615229715295
   PubMed Web of Science ®Google Scholar
• O’SheaSD, TaylorNF, ParatzJ. Measuring muscle strength for people with chronic obstructive pulmonary disease: retest reliability of hand-held dynamometry. Arch Phys Med Rehabil. 2007;88(1):32–36. doi:10.1016/j.apmr.2006.10.00217207672
   PubMed Web of Science ®Google Scholar
• MahlerD, WellsC. Evaluation of clinical methods for rating dyspnea. Chest. 1988;93(3):580–586. doi:10.1378/chest.93.3.5803342669
   PubMed Web of Science ®Google Scholar
• JonesPW, HardingG, BerryP, WiklundI, ChenWH, Kline LeidyN. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34:648–654. doi:10.1183/09031936.0010250919720809
   PubMed Web of Science ®Google Scholar
• HerreroMJ, BlanchJ, PeriJM, et al. A validation study of the hospital anxiety and depression scale (HADS) in a Spanish population. Gen Hosp Psychiatry. 2003;25(4):277–283. doi:10.1016/S0163-8343(03)00043-412850660
   PubMed Web of Science ®Google Scholar
• HankinsonJL, OdencrantzJR, FedanKB. Spirometric reference values from a sample of the general U. S Population Am J Respir Crit Care Med. 1999;159:179–187. doi:10.1164/ajrccm.159.1.97121089872837
   PubMed Web of Science ®Google Scholar
• KabboordAD, Van EijkM, Van DingenenL, et al. Reliability and usability of a weighted version of the functional comorbidity index. Clin Interv Aging. 2019;11(14):289–299.
   Web of Science ®Google Scholar
• HintzeJ. PASS 2020, V20.0.1 [Computer Software]. Kaysville, Utah: Number Cruncher Statistical Software; 2020.
   Google Scholar
• Medinas AmorósM, Mas-TousC, Renom-SotorraF, et al. Health-related quality of life is associated with COPD severity: a comparison between the GOLD staging and the BODE index. Chron Respir Dis. 2009;6:75–80. doi:10.1177/147997230810155119411567
   PubMedGoogle Scholar
• HuYH, LiangZY, XuLM, et al. Comparison of the clinical characteristics and comprehensive assessments of the 2011 and 2017 GOLD classifications for patients with COPD in China. Int J Chron Obstruct Pulmon Dis. 2018;13:3011–3019. doi:10.2147/COPD.S17466830319249
   PubMed Web of Science ®Google Scholar
• SeymourJM, SpruitMA, HopkinsonNS, et al. The prevalence of quadriceps weakness in COPD and the relationship with disease severity. Eur Respir J. 2010;36(1):81–88. doi:10.1183/09031936.0010490919897554
   PubMed Web of Science ®Google Scholar
• DingB, JudgeD, SmallM, et al. Functional performance in patients with COPD: association with treatment regimen, GOLD group, lung function, and symptom burden in a cross-sectional study. Int J Chron Obstruct Pulmon Dis. 2018;13:2785–2796. doi:10.2147/COPD.S17039130233169
   PubMed Web of Science ®Google Scholar
• PolkeyMI, MoxhamJ. Attacking the disease spiral in chronic obstructive pulmonary disease. Clin Med. 2006;6:190–196. doi:10.7861/clinmedicine.6-2-190
   PubMed Web of Science ®Google Scholar
• ManWD, SolimanMG, NikoletouD, et al. Non-volitional assessment of skeletal muscle strength in patients with chronic obstructive pulmonary disease. Thorax. 2003;58(8):665–669. doi:10.1136/thorax.58.8.66512885979
   PubMed Web of Science ®Google Scholar
• SongJH, LeeCH, UmSJ, et al. Clinical impacts of the classification by 2017 GOLD guideline comparing previous ones on outcomes of COPD in real-world cohorts. Int J Chron Obstruct Pulmon Dis. 2018;13:3473–3484. doi:10.2147/COPD.S17723830498337
   PubMed Web of Science ®Google Scholar
• MenezesAM, WehrmeisterFC, Perez-PadillaR, et al. The PLATINO study: description of the distribution, stability, and mortality according to the Global Initiative for Chronic Obstructive Lung Disease classification from 2007 to 2017. Int J Chron Obstruct Pulmon Dis. 2017;12:1491–1501. doi:10.2147/COPD.S13602328553101
   PubMed Web of Science ®Google Scholar
• Cabrera LópezC, Casanova MacarioC, Marín TrigoJM, et al. Comparison of the 2017 and 2015 Global Initiative for Chronic Obstructive Lung Disease Reports. Am J Respir Crit Care Med. 2018;197(4):463–469. doi:10.1164/rccm.201707-1363OC29099607
   PubMed Web of Science ®Google Scholar
• BikovA, HorváthA, TomisaG, BártfaiL, BártfaiZ. Changes in the Burden of comorbidities in patients with COPD and Asthma–COPD overlap according to the GOLD 2017 recommendations. Lung. 2018;196(5):591–599. doi:10.1007/s00408-018-0141-730008015
   PubMed Web of Science ®Google Scholar
• GriffithsTL, BurrML, CampbellIA, et al. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet. 2000;355(9201):362–368. doi:10.1016/S0140-6736(99)07042-710665556
   PubMed Web of Science ®Google Scholar
• WedzichaJA, BestallJC, GarrodR, et al. Randomized controlled trial of pulmonary rehabilitation in severe chronic obstructive pulmonary disease patients, stratified with the MRC dyspnoea scale. Eur Respir J. 1998;12:363–369. doi:10.1183/09031936.98.120203639727786
   PubMed Web of Science ®Google Scholar
• O’DonnellDE, HernandezP, KaplanA, et al. Canadian thoracic society recommendations for management of chronic obstructive pulmonary disease - 2008 update - highlights for primary care. Can Respir J. 2008;15 Suppl A:1A–8A. doi:10.1155/2008/641965
   PubMed Web of Science ®Google Scholar
• DoddJW, HoggL, NolanJ, et al. The COPD assessment test (CAT): response to pulmonary rehabilitation. A multicentre, prospective study. Thorax. 2011;66(5):425–429. doi:10.1136/thx.2010.15637221398686
   PubMed Web of Science ®Google Scholar